GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Price-to-Free-Cash-Flow

Whanin Pharm Co (XKRX:016580) Price-to-Free-Cash-Flow : 163.22 (As of May. 31, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Price-to-Free-Cash-Flow?

As of today (2025-05-31), Whanin Pharm Co's share price is ₩11790.00. Whanin Pharm Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩72.24. Hence, Whanin Pharm Co's Price-to-Free-Cash-Flow Ratio for today is 163.22.

The historical rank and industry rank for Whanin Pharm Co's Price-to-Free-Cash-Flow or its related term are showing as below:

XKRX:016580' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.84   Med: 19.49   Max: 163.22
Current: 163.22

During the past 13 years, Whanin Pharm Co's highest Price-to-Free-Cash-Flow Ratio was 163.22. The lowest was 7.84. And the median was 19.49.

XKRX:016580's Price-to-Free-Cash-Flow is ranked worse than
91.78% of 523 companies
in the Drug Manufacturers industry
Industry Median: 23.55 vs XKRX:016580: 163.22

Whanin Pharm Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was ₩157.50. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩72.24.

During the past 13 years, Whanin Pharm Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 108.80% per year. The lowest was -50.00% per year. And the median was 12.55% per year.


Whanin Pharm Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Whanin Pharm Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Price-to-Free-Cash-Flow Chart

Whanin Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.54 8.89 - - -

Whanin Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 154.22

Competitive Comparison of Whanin Pharm Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Price-to-Free-Cash-Flow falls into.


;
;

Whanin Pharm Co Price-to-Free-Cash-Flow Calculation

Whanin Pharm Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=11790.00/72.236
=163.22

Whanin Pharm Co's Share Price of today is ₩11790.00.
Whanin Pharm Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩72.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Whanin Pharm Co  (XKRX:016580) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Whanin Pharm Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines